Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I O Tassiulas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Rheumatology|September 1, 1996
Lupus nephritisJ C Davis, I O Tassiulas, D T Boumpas
Clinical Nephrology|September 10, 1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapyD T Boumpas, I O Tassiulas, T A Fleisher, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effectsK Takada, C L Danning, T Kuroiwa, et al.
The Journal of Rheumatology|September 11, 1998
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritisJ C Davis, B J Fessler, I O Tassiulas, et al.
Clinical Nephrology|August 26, 1998
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patientsI O Tassiulas, I Aksentijevich, J E Salmon, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Rheumatology|September 1, 1996
Lupus nephritisJ C Davis, I O Tassiulas, D T Boumpas
Clinical Nephrology|September 10, 1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapyD T Boumpas, I O Tassiulas, T A Fleisher, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effectsK Takada, C L Danning, T Kuroiwa, et al.
The Journal of Rheumatology|September 11, 1998
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritisJ C Davis, B J Fessler, I O Tassiulas, et al.
Clinical Nephrology|August 26, 1998
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patientsI O Tassiulas, I Aksentijevich, J E Salmon, et al.
Pageof 1